These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 31783527)

  • 21. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.
    Uranbileg B; Ikeda H; Kurano M; Enooku K; Sato M; Saigusa D; Aoki J; Ishizawa T; Hasegawa K; Kokudo N; Yatomi Y
    PLoS One; 2016; 11(2):e0149462. PubMed ID: 26886371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational aspects of sphingosine 1-phosphate biology.
    Pyne S; Pyne NJ
    Trends Mol Med; 2011 Aug; 17(8):463-72. PubMed ID: 21514226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugging sphingosine kinases.
    Santos WL; Lynch KR
    ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells.
    Liu X; Zhang QH; Yi GH
    Mol Cell Biochem; 2012 Apr; 363(1-2):21-33. PubMed ID: 22113622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).
    Sanllehí P; Abad JL; Casas J; Delgado A
    Chem Phys Lipids; 2016 May; 197():69-81. PubMed ID: 26200919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
    Schwalm S; Pfeilschifter J; Huwiler A
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):44-9. PubMed ID: 23789924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The drug development based on sphingosine-1-phosphate signaling pathway].
    Bai J; Hu JP
    Yao Xue Xue Bao; 2016 Dec; 51(12):1822-8. PubMed ID: 29908533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.
    Karliner JS
    Biochim Biophys Acta; 2013 Jan; 1831(1):203-12. PubMed ID: 22735359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and metabolism of bioactive sphingosine-1-phosphate.
    Le Stunff H; Milstien S; Spiegel S
    J Cell Biochem; 2004 Aug; 92(5):882-99. PubMed ID: 15258913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting sphingosine-1-phosphate signaling for cancer therapy.
    Xie Z; Liu H; Geng M
    Sci China Life Sci; 2017 Jun; 60(6):585-600. PubMed ID: 28623546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.
    Orr Gandy KA; Obeid LM
    Biochim Biophys Acta; 2013 Jan; 1831(1):157-66. PubMed ID: 22801037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells.
    Eigenbrod S; Derwand R; Jakl V; Endres S; Eigler A
    Immunol Invest; 2006; 35(2):149-65. PubMed ID: 16698674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sphingosine 1-phosphate signalling in cancer.
    Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
    Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme.
    Bien-Möller S; Lange S; Holm T; Böhm A; Paland H; Küpper J; Herzog S; Weitmann K; Havemann C; Vogelgesang S; Marx S; Hoffmann W; Schroeder HW; Rauch BH
    Oncotarget; 2016 Mar; 7(11):13031-46. PubMed ID: 26887055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of sphingosine kinase by bovine viral diarrhea virus NS3 is crucial for efficient viral replication and cytopathogenesis.
    Yamane D; Zahoor MA; Mohamed YM; Azab W; Kato K; Tohya Y; Akashi H
    J Biol Chem; 2009 May; 284(20):13648-13659. PubMed ID: 19293152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
    Maceyka M; Payne SG; Milstien S; Spiegel S
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.
    Hait NC; Oskeritzian CA; Paugh SW; Milstien S; Spiegel S
    Biochim Biophys Acta; 2006 Dec; 1758(12):2016-26. PubMed ID: 16996023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes.
    Ito K; Anada Y; Tani M; Ikeda M; Sano T; Kihara A; Igarashi Y
    Biochem Biophys Res Commun; 2007 May; 357(1):212-7. PubMed ID: 17418101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors.
    Pyne S; Pyne N
    Pharmacol Ther; 2000 Nov; 88(2):115-31. PubMed ID: 11150592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sphingosine kinase inhibitors: A patent review.
    Cao M; Ji C; Zhou Y; Huang W; Ni W; Tong X; Wei JF
    Int J Mol Med; 2018 May; 41(5):2450-2460. PubMed ID: 29484372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.